Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2011
05/19/2011CA2778140A1 Dual variable domain immunoglobulins and uses thereof
05/18/2011EP2322538A1 Compounds for the diagnosis of diseases associated with VCAM expression
05/18/2011EP2322500A1 Fluoro-labeled homo-glutamate derivatives and precursors thereof
05/18/2011EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof
05/18/2011EP2322171A2 Fluorine labeled L-glutamic acid derivatives
05/18/2011EP2320956A2 Radiolabelled trp m8 receptor ligands
05/18/2011EP2320954A1 Diagnostic agents selective against metalloproteases
05/18/2011EP1379499B1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
05/18/2011CN102065906A Methods for radiolabelling macromolecules
05/18/2011CN102065905A Methods for radiolabelling synthetic polymers
05/18/2011CN102060880A 99mTc(CO)3-DGDTC complex as well as preparation method and application thereof
05/18/2011CN101322849B Radioactive sustained-release particle and preparation and use thereof
05/18/2011CN101259290B Target tumor intervention therapeutic agent, its preparation and application
05/17/2011US7943580 Polypeptide and the use thereof
05/17/2011US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies
05/17/2011US7943312 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides
05/17/2011US7943117 Method for testing radiochemical purity of Tc-99m-TRODAT-1
05/17/2011CA2466525C Synthesis of small particles
05/14/2011CA2739869A1 Radiolabelled inhibitors of the glycine 1 transporter
05/12/2011WO2011056983A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates
05/12/2011WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines
05/12/2011WO2011056288A1 Functionalized nanomaterials for dermal decorporation, chelation, therapy, and sorbent dialysis of radiounuclides and toxins
05/12/2011WO2010065906A3 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
05/12/2011US20110111003 Stable cell binding chimeric peptides
05/12/2011US20110110855 Novel ghrelin analogues
05/12/2011US20110110854 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
05/12/2011US20110110853 Primitive vascular progenitor cells and uses thereof
05/12/2011US20110110852 Multivalent Antibodies and Uses Therefor
05/12/2011US20110110851 Multivalent Immunoglobulin-Based Bioactive Assemblies
05/12/2011US20110110850 Compounds for therapy and diagnosis
05/12/2011CA2780216A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates
05/12/2011CA2776563A1 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines
05/11/2011EP2319850A1 Optically active -amino acid into which bsh is introduced and method for synthesizing the same
05/11/2011EP2319849A1 Method for producing bsh derivative and bsh derivative
05/11/2011EP2319544A1 Cellular labeling for nuclear magnetic resonance techniques
05/11/2011EP2318366A2 Psma-binding agents and uses thereof
05/11/2011EP2115177B1 Method for the elution of 18f fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabeling without any evaporation step
05/11/2011CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
05/11/2011CN101153013B Method of producing DL-tyrosine -15N
05/10/2011US7939625 Somatostatin analogues
05/10/2011US7939280 Marker for inflammatory conditions
05/10/2011US7939080 HER-2 binding antagonists
05/10/2011US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
05/10/2011CA2416293C Somatostatin analogues
05/05/2011WO2011051324A1 Radiolabelled pde10 ligands
05/05/2011US20110105896 Multimodal imaging fiducial marker
05/05/2011US20110105380 Protection of Nano-Scale Particles from Immune Cell Uptake
05/05/2011US20110104056 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system
05/05/2011US20110104055 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
05/05/2011US20110104054 Small-Molecule HSP90 Inhibitors
05/05/2011US20110104053 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM
05/05/2011US20110104052 Methods of synthesis and use of chemospheres
05/05/2011US20110104051 Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents
05/05/2011US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
05/05/2011US20110104049 Method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
05/05/2011CA2776240A1 Radiolabelled pde10 ligands
05/04/2011EP2316494A1 Ethylenedicysteine (EC)-neomycin conjugates and their use in tissue specific disease imaging
05/04/2011EP2316493A2 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
05/04/2011EP2316455A1 Pharmaceutical compositions for treating cancer
05/04/2011EP2315604A2 Dicarba-analgues of octreotide
05/04/2011EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
05/04/2011CN102040631A Preparation method and application of <99m>technetium (Tc) labeled 2-nitroimidazole xanthate complexes
05/04/2011CN101538249B Preparation method of tritium or deuterium-labeled cyadox
05/04/2011CN101461944B Magnetic polyacrylic acid modified carbon nano-tube medicament carrier
05/03/2011US7935346 Medicament for the two-step perioperative therapy of solid tumours
04/2011
04/28/2011WO2011050262A2 Dual variable domain immunoglobulins and uses thereof
04/28/2011WO2011049405A2 Optical imaging contrast agent, use and device thereof
04/28/2011WO2011026824A3 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
04/28/2011WO2011021001A8 Peptidic conjugates comprising polyhistidine sequence and free cysteine and their uses in imaging
04/28/2011WO2011012435A3 Active ingredient and method for testing an active ingredient
04/28/2011WO2010148177A3 Compounds, compositions, methods of synthesis, and methods of treatment
04/28/2011WO2010144846A3 Gastrointestinal disease or disorder imaging and treatment
04/28/2011US20110097274 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters
04/28/2011US20110097269 Phenyloxyaniline derivatives
04/28/2011US20110097268 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers
04/28/2011US20110097267 Compositions for imaging pain and stress in vivo
04/28/2011US20110097266 Bombesin Analog Peptide Antagonist Conjugates
04/28/2011US20110097264 Radiolabeling method using multivalent glycoligands as hepatic receptor imaging agent
04/28/2011US20110097263 Kit formulation for the preparation of immunoliposome drug in combined bimodality radiochemotherapy
04/28/2011US20110097262 NOVEL ANTI-cMET ANTIBODY
04/28/2011US20110097261 Amigo-2-inhibitors for treating, diagnosing or detecting cancer
04/28/2011CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof
04/28/2011CA2778176A1 Dual variable domain immunoglobulins and uses thereof
04/27/2011EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies
04/27/2011EP2313504A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
04/27/2011EP2313430A1 Muteins of hngal and related proteins with affinity for a given target
04/27/2011CN102036936A Novel [F-18]-labelled l-glutamic acid and l-glutamine derivatives (II), use thereof and method for their production
04/27/2011CN102036684A RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
04/27/2011CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof
04/27/2011CN102030797A Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof
04/27/2011CN102028962A 99mTc-MIBI labeled lyophilized product medicine box and preparation method thereof
04/26/2011US7932225 Glue composition for lung volume reduction
04/26/2011US7931890 Targeted combination immunotherapy of cancer and infectious diseases
04/26/2011CA2496611C Agent delivery particle
04/26/2011CA2477060C Flow cell and method of separating carrier-free radionuclides and their radiochemical reaction
04/21/2011WO2011047262A2 Dual variable domain immunoglobulins and uses thereof
04/21/2011WO2011045415A2 New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
04/21/2011WO2011044671A1 Porphyrin nanovesicles
04/21/2011US20110092806 Compounds Comprising a Biological Target Recognizing Part, Coupled to a Signal Part Capable of Complexing Gallium
04/21/2011US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 243